Results 261 to 270 of about 573,785 (398)

A study of left ventricular hypertrophy with body surface isopotential maps

, 1986
Kazuo Ihoriya
openalex   +2 more sources

International Contrast Ultrasound Society Safety Round Table

Journal of Ultrasound in Medicine, EarlyView.
The international Contract Ultrasound Society (ICUS) held a round table discussion on the safety of ultrasound contrast agents for cardiology, radiology, and pediatrics on September 4, 2024. The panel included international experts on ultrasound contrast.
Richard G. Barr, Jordan Strom, Dirk A. Clevert, Stephanie R Wilson, Thomas Porter, Kassa Darge   +5 more
wiley   +1 more source

Sex Difference in the Association Between Regional Adipose Tissue and Left Ventricular Hypertrophy. [PDF]

J Clin Med
Cho IJ, Lee SE, Pyun WB.
europepmc   +1 more source

Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis From Other Causes of Concentric Left Ventricular Hypertrophy

Circulation Cardiovascular Imaging, 2013
Dan Liu, K. Hu, M. Niemann, S. Herrmann, M. Čikeš, S. Störk, P. Gaudron, S. Knop, G. Ertl, B. Bijnens, F. Weidemann   +10 more
semanticscholar   +1 more source

Sacubitril/Valsartan Ameliorates Inflammation and Oxidative Stress in Hypertensive Heart Disease by Upregulating CAMKK2 Protein and Modulating the AMPK/AKT/GSK‐3β Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Sacubitril/valsartan (Sac/Val) has emerged as an effective compound with myocardium‐protective functions in experimental and clinical trials for heart failure. This study investigated the function of Sac/Val in hypertensive heart disease (HHD) and explored the underlying mechanism.
Yan‐Jun Yang, Jiu‐Sheng Li
wiley   +1 more source

Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism

HYPERTENSION, 2013
G. Rossi, M. Cesari, C. Cuspidi, G. Maiolino, M. Cicala, V. Bisogni, F. Mantero, A. Pessina   +7 more
semanticscholar   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, EarlyView.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

Influence of Echocardiographic Criteria on the Prevalence and Prognostic Implication of Left Ventricular Hypertrophy: A Nationwide Population-Based Study. [PDF]

J Am Heart Assoc
Cai A, Zheng C, Song Q, Qiu J, Wang X, Hu Z, Cao X, Tian Y, Gu R, Pei X, Yu X, Chang C, Tuerdi N, Zhang Y, Tian Y, Feng Y, Wang Z.   +16 more
europepmc   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Diagnostic and prognostic value of ECG-predicted hypertension-mediated left ventricular hypertrophy using machine learning. [PDF]

J Hypertens
Naderi H, Ramírez J, Van Duijvenboden S, Ruiz Pujadas E, Aung N, Wang L, Chamling B, Dörr M, Markus MRP, Chahal CAA, Lekadir K, Petersen SE, Munroe PB.   +12 more
europepmc   +1 more source